Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study BioSpace Source link
Daily Emollients Reduce Pediatric Eczema Risk, Study Finds Medscape Source link
Pfizer’s New Pediatric Eczema Study: A Potential Game-Changer? TipRanks Source link
Pfizer’s New Study on Abrocitinib: A Potential Game-Changer for Pediatric Eczema TipRanks Source link